Target intelligence / Profile preview

Complement C1q subcomponent subunit A (C1QA)

Target
C1QA
Molecular classification
Other (Complement component/protein), Pattern recognition molecule, Innate immunity protein
01

Overview

Complement C1q subcomponent subunit A (C1QA) is one of three polypeptide chains (A, B, C) forming the C1q molecule, the recognition protein of the classical complement pathway of the innate immune system[2][3][4]. C1q, together with C1r and C1s, forms the C1 complex that binds to antigen-antibody complexes, initiating the classical complement cascade and amplifying immune responses[3][4][5]. C1q is referred to as a pattern recognition molecule for its ability to bind various ligands, such as immunoglobulins, apoptotic cell surfaces, and microbial components, thereby mediating immune complex clearance and modulating inflammation, apoptosis, angiogenesis, and synaptic pruning in the central nervous system[1][2][4]. The C1QA chain contributes to the collagen-like region and the globular domain of the C1q molecule, which is essential for binding to pathogens, immune complexes, or cell debris[1]. Deficiency or dysfunction of C1q or its subunits is strongly associated with severe autoimmune diseases like systemic lupus erythematosus (SLE), glomerulonephritis, and has roles in neurodegenerative and cardiovascular disease[2][3][5]. Current therapies indirectly modulate C1q activity but direct C1QA-targeting drugs remain experimental.

Other names
Complement C1q A chainC1QAC1QD1C1q-Acomplement C1q subcomponent subunit Acomplement C1q chain Acomplement component 1, q subcomponent, A chaincomplement component 1, q subcomponent, alpha polypeptidecomplement component C1q, A chain
02

Mechanism of action

Inhibition of complement activation (via classical pathway blockade); antibody binding to inhibit or modulate C1q-mediated immune complex clearance; modulation of inflammatory, phagocytic, or immune tolerance pathways

03

Biological functions

Immune responseComplement activation (classical pathway)Pattern recognitionClearance of apoptotic cells and debrisRegulation of cellular eventsModulation of inflammationSynaptic pruning (in central nervous system)Angiogenesis
04

Disease associations

Autoimmune diseases (systemic lupus erythematosus)GlomerulonephritisNeurodegenerative diseaseCardiovascular diseasePregnancy disorders (e.g., pre-eclampsia)CancerInfectionInflammation
05

Safety considerations

Increased risk of infections with complement inhibitionRisk of immune dysregulation and autoimmunity with C1q deficiencyBroad immune suppression with complement-targeting therapies[3][5]
06

Interacting drugs

None with direct therapeutic approval targeting C1q or C1QA; C1q inhibitors and complement inhibitors (e.g., C1 esterase inhibitor) are being investigated or used in select rare diseases, but few are directly selective for C1QA[4][5]
07

Biomarkers

Serum C1q level for diagnosis or monitoring in systemic lupus erythematosus and inherited C1q deficienciesC1q deposition in tissue biopsies (e.g., lupus nephritis)

Beyond the preview

Go deeper on Complement C1q subcomponent subunit A (C1QA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement C1q subcomponent subunit A (C1QA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call